6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
Just now	SFG Quarterly Activities/Appendix 4CCash Flow Report
Just now	BSA Announces On-Market Share Buy-Back
Just now	Placement
Just now	Q3 FY26 Activities Report and Appendix 4C
Just now	FY26 Q1 Quarterly Activities Report and Appendix 4C

About

Xilio Development Inc (NASDAQ:XLO) — investor relations, events, news, and company updates on 6ix.

Latest News

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting

Xilio Therapeutics Announces 1-for-14 Reverse Stock Split

Financials

Revenue

$43.77 M

Market Cap

$49.21 M

EPS

-58.66

Community Chat

Ask AI